Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Vial Kit

Clinical trial NCT05282004 · COMPLETED

Trial details

NCT number: NCT05282004
Sponsor: Sandoz
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Neovascular Age-related Macular Degeneration (nAMD)

Start date: 2022-05-16
Primary completion: 2022-09-07
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.